Council on Foreign Relations report details U.S. strategies to lessen pharmaceutical reliance on China

A new report warns the U.S. pharmaceutical supply chain is vulnerable to China's potential weaponization, similar to rare-earth minerals. The Council on Foreign Relations report identifies three key choke points: reliance on China for raw materials, manufacturing, and biotechnology research and development. The U.S. must address these dependencies with coordinated measures and urgency to avoid future crises, the report concludes.